Irina A. Dubina

Irina A. Dubina

Auto-generated profile, based on publicly available information

Irina A. Dubina

Pavlov First Saint Petersburg State Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
IRIrina G. Rekhtina
Irina G. Rekhtina
LMLarisa P. Mendeleeva
Larisa P. Mendeleeva
NSNatalia P. Soboleva
Natalia P. Soboleva
IDIrina A. Dubina
Irina A. Dubina
MPMargarita Iu. Pervakova
Margarita Iu. Pervakova
SLSergey V. Lapin
Sergey V. Lapin
Paraprotein is a laboratory biomarker of plasma cell tumors and other lymphoproliferative diseases. Its determination is necessary for diagnosing, monitoring and assessment of therapy effectiveness. The lecture presents the main methods of qualitative and quantative analysis of monoclonal proteins: gel electrophoresis, capillary electrophoresis, immunofixation and nephelometry features, possibilities and limitations are reviewed. The main sources of errors and artifacts during these studies are considered. Also the difficulties in the diagnosis and interpretation of the results of serum and urine tests are highlighted.

20 January 2025 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
AKA. G. Khachaturian
A. G. Khachaturian
VNVladimir Nazarov
Vladimir Nazarov
IDI. A. Dubina
I. A. Dubina
SLSergey V. Lapin
Sergey V. Lapin
DSD. V. Sidorenko
D. V. Sidorenko
ВЭВ. Л. Эмануэль
В. Л. Эмануэль
Beta-thalassemia being one of the most widespread monogenic diseases in the world is characterized by the HBB gene mutations leading to beta-globin chain decrease. Despite of the specific laboratory features diagnosis of beta-thalassemia may seem difficult especially when speaking of minor forms and carriers. The common diagnostic standard includes complete blood count with analysis of hematological indices, iron deficiency exclusion and examination of hemoglobin fractions. The last and the crucial step is providing molecular-genetic study of HBB gene as the method allowing to verify the diagnosis. The beta-thalassemia pathogenesis, comprehensive genetic classification and various laboratory diagnostics tools are discussed in this review. There exists huge knowledge about beta-thalassemia prevalence in endemic regions but little is known of beta-thalassemia incidence in nonendemic countries, e.g., Russian Federation. Nevertheless, studying beta-thalassemia prevalence in Russia remains relevant considering multi ethnicity of Russian Federation. This review presents the diagnostics algorithm with the use of HBB gene Sanger sequencing and the results of beta-thalassemia prevalence pilot research. According to the data obtained the minimal possible beta-thalassemia incidence in Moscow accounts for 0.16 %.

17 January 2023 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
NDN. V. Dunaeva
N. V. Dunaeva
SRS. Yu. Romanova
S. Yu. Romanova
IDI. A. Dubina
I. A. Dubina
SLSergey V. Lapin
Sergey V. Lapin
VRVadim Rassokhin
Vadim Rassokhin
DGD. A. Gusev
D. A. Gusev
Introduction. Several viruses including hepatitis C virus (HCV) and human immunodeficiency virus (HIV) can induce vasculitis.Aim. We aimed to study the incidence, risk factors, and severity of skin vasculitis in patients with HCV and HCV/HIV coinfection.Patients and Methods. The study group included 331 patients (254 patients with HCV and 77 patients with HCV/HIV coinfection) referred to a specialized hepatology center for antiviral therapy of HCV infection.Results. Skin vasculitis was found in 21% (95% CI: 17–25%) of cases, n = 69/331. Skin vasculitis was observed in in 20% of patients infected with HCV (95% CI: 15–25%) and in 25% of HIV/HCV co-infected patients (95% CI; 16–35%), χ2 = 0,892, р = 0,345. Most patients with vasculitis infected with HCV had cryoglobulinemia (94%, n = 47/50), meanwhile, in HIV/HCV co-infected patients, cryoglobulinemia was found in 63% cases (n = 12/19), χ2 = 10.568, р = 0.001. Multiple regression analysis showed that skin vasculitis was related with cryoglobulinemia (OR = 6,928, 95% CI: 3.245–14.790, р < 0.001), liver cirrhosis (OR = 2.015, 95% CI: 1.062–3.824, р = 0.032), duration of overt HCV infection (OR = 1.057, 95% CI: 1.021–1.094, р = 0.002), patients age (OR = 1.029, 95% CI: 1.002–1.057, р = 0.033) and inversely related with plasma alanine transaminase (OR 0.433, 95% CI: 0.229–0.820, р = 0.010). The statistical model was normalized for gender, HIV-positivity and bilirubin levels, and regression equation constant was 4.398 (p < 0.001). The intensity of skin rashes was comparable in HCV infected and HCV/HIV co-infected patients (χ2 = 6.741, р = 0.081), and was highly correlated with cryoglobulin levels both in HCV infected (r = 0.788, p < 0.001), and HCV/HIV co-infected patients (r = 0.909, p = 0.001).Conclusion. Skin vasculitis was found in 20–25% of cases among patients with HCV infection and HCV/HIV co-infection. Cryoglobulinemia was the main factor associated with skin vasculitis, and severity of skin lesions was closely related with cryoglobulin levels.

19 March 2024 in Russian journal of hematology and transfusiology
Verified
Journal Article
Open access
PDF file
AKA. G. Khachaturian
A. G. Khachaturian
VNVladimir Nazarov
Vladimir Nazarov
SLSergey V. Lapin
Sergey V. Lapin
DSD. V. Sidorenko
D. V. Sidorenko
IDI. A. Dubina
I. A. Dubina
ВЭВ. Л. Эмануэль
В. Л. Эмануэль
Лабораторная характеристика гемоглобинопатий